Reading Time:
Pathology
Neurodegenerative disorder characterized by Parkinsonism, visual hallucinations and dementia
Lewy bodies (inclusion bodies containing alpha-synuclein and ubiquitin)
Time of onset of cognitive symptoms concurrently or within 1 year of Parkinsonism
Aetiology
Most cases are sporadic affecting patients between 50 and 85 years.
Signs
Parkinsonian features of rigidity and bradykinesia but fewer resting tremors.
Symptoms
Cognitive Symptoms: Impaired memory, apathy, executive dysfunction and
visuospatial abilities.
Psychiatric Symptoms: Delusions, visual hallucinations and emotional lability.
Autonomic symptoms: Dry skin, orthostatic hypotension and sexual dysfunction
Other: Frequent falls, transient episodes of depressed consciousness
Investigations
Imaging: MRI/CT brain to exclude other causes of dementia
DaT Scan: Reduced uptake of radioactive isotope in the basal ganglia
Treatment
Dopaminergic Therapy: Levodopa for Parkinsonism but response is usually poor
Cholinesterase Inhibitors: Donepezil for cognitive symptoms
Atypical Antipsychotics: Quetiapine for psychiatric symptoms and hallucinations
Avoid neuroleptic drugs such as haloperidol.
Prognosis
Mean survival 8 years from onset.
No disease modifying treatment is currently available.
Infection, incontinence, falls, self-neglect
Key Facts
Lorem ipsum dolor sit amet, sapien platea morbi dolor lacus nunc, nunc ullamcorper. Felis aliquet egestas vitae, nibh ante quis quis dolor sed mauris.
Key Images
Lorem ipsum dolor sit amet, sapien platea morbi dolor lacus nunc, nunc ullamcorper. Felis aliquet egestas vitae, nibh ante quis quis dolor sed mauris.
Key References
Lorem ipsum dolor sit amet, sapien platea morbi dolor lacus nunc, nunc ullamcorper. Felis aliquet egestas vitae, nibh ante quis quis dolor sed mauris.